A Joint Process to support reforms of the Global Health Architecture (GHA) cdn.who.int/media/docs/d... @who.int

Guide to the Copyright and Related Rights Treaties Administered by WIPO, Second edition www.wipo.int/edocs/pubdoc...

IISD on #MC14

On 9 April 2026, WHO Member States will convene an informal consultation on the Global Action Plan for for Antimicrobial Resistance (to discuss the outsanding issue of technology transfer which had references to VMAT).

Professor Filippo Arfini, University of Parma, Parma, Italy - Information Session on Geographical Indications @wipo.int @manonress.bsky.social

WIPO will "prepare and circulate a draft survey on the current approaches to protection of new technological designs including the protected designs, holographic designs and the virtual augmented reality designs" based on the US proposal: www.wipo.int/edocs/mdocs/... @wipo.int #SCT49

GHF: "Experts also highlighted the limitations of using Unique Persistent Identifiers (UPIs) as a de facto function for traceability."

The 160th session of the @who.int Executive Board serves as a selection committee to nominate "up to three candidates for consideration by the World Health Assembly, which then appoints the Director-General". #EB160 #WHA80 @who.int

TWN: "Colombia, Bangladesh and India pushed for any extension on e-commerce to be linked to the TRIPS non-violation complaints (TNVCs) moratorium, which prevents WTO members from bringing non-violation complaints under the TRIPS Agreement on intellectual property."

"This pause is not a setback; it's an opportunity. It allows us to reflect, to consult further with our capitals, and to return with renewed clarity and flexibility not to keep negotiating indefinitely but to continute and to close, to close the deal. That's a choice, and it's the right one." #IGWG6

"The IGWG decided to hold a resumed session of the sixth meeting of the IGWG from 27 April to 1 May 2026, including stocktaking in the middle of the week in view of the mandate of the IGWG to submit its outcome regarding the PABS Annex to the Seventy-ninth World Health Assembly." #IGWG6 @who.int

#IGWG6 - Last day of the March 2026 session - WHO house kitty, Tim Tam diplomacy, and "On the compatability of Pathoplexus and user registration".

The "Hybrid PABS System" proposal - Yesterday, word of a "compromise" solution made the rounds of #IGWG6 - I am not sure how much traction this received.

Draft PABS Annex onscreen text - Friday 27 March 2026 #IGWG6

The new version of the Draft WIPO Broadcasting Organizations Treaty was published by @wipo.int on 18 March 2026. www.wipo.int/edocs/mdocs/... #SCCR48

Indonesia on behalf of the Group for Equity: "• First, access and benefit sharing must be treated on an equal footing. The level of benefit-sharing obligations must be proportionate to the level of access expected from the System." #IGWG6

Pakistan: "Trust is the currency of this negotiation. If outcomes remain imbalanced, weakly defined, or deferred, confidence in this process will erode further." #IGWG6 @who.int

The appointment of @wipo.int Deputy Directors General and Assistant Directors General is scheduled for Thursday, 9 July 2026 at the Sixty-Eighth Series of Meetings of the Assemblies of the Member States of WIPO. www.wipo.int/edocs/mdocs/...

A Moment of Reckoning in Global Health Negotiations: Weak Deal, Good Deal or No Deal on the Pathogen Access & Benefit Sharing? A PABS Cheat Sheet from Geneva Health Files ahead of IGWG6 @who.int newsletter.genevahealthfiles.com/a-moment-of-...

Lancet: "From next month, patents for semaglutide will expire in several countries, including in Brazil, Canada, China, India, and Türkyie—amounting to about 40% of the world's population. Manufacturers in China and India stand poised to launch a raft of biosimilars."

Intense schedule for @who.int #IGWG6 negotiators endeavoring to wrap up negotiations on pathogen access and benefit sharing. No dinner breaks? #PandemicTreaty

Some slides from Chris Horton, Executive Vice President, Strategic Technology, Universal Music Group. @wipo.int Artificial Intelligence Infrastructure Interchange (AIII)

An obstacle to an HIV cure is that the viral protease enzyme is like a jewel thief that dodges laser sensors, which, when tripped, cause death of infected cells. Drugs can force protease to stand up, potentially reducing reservoirs of latently infected cells. www.science.org/content/arti...

The Lancet: "Since 2022, WHO has observed a spike in reports of falsified GLP-1 receptor agonists, which have been detected in almost 60 countries."

KEI drew attention to the CBD's 2022 decision on Digital sequence information on genetic resources www.cbd.int/doc/decision... #IGC52 @wipo.int @keiwashdc.bsky.social

Draft programme of work - #IGWG6

DRAFT MINISTERIAL DECLARATION ON ENABLING THE TRANSFER OF RELEVANT AND ADVANCED TECHNOLOGY FOR TRADE - Communication from India @wto.org

Marco D'Alessandro presenting on the WIPO GR treaty. #IGC52